Posters & Publications

Date Title View
Sep 7, 2017 CIC 2017 Indoximod Plus KEYTRUDA (pembrolizumab) Phase 2
Jun 22, 2017 EHA 2017 Phase I Indoximod plus Idarubicin & Cytarabine for Newly Diagnosed Acute Myeloid Leukemia
Jun 5, 2017 ASCO 2017 Phase II Double-blind study of Metastatic Castration-resistant Prostate Cancer
Apr 4, 2017 AACR Plenary 2017 Indoximod plus Keytruda (pembrolizumab) Phase II Interim in Advanced Melanoma
Apr 4, 2017 AACR 2017 NLG802 Prodrug Poster Presentation
Nov 22, 2016 SNO 2016 Indoximod + Temozolomide Brain Tumor Trial
Jun 5, 2016 ASCO 2016 Melanoma indoximod
Jun 5, 2016 ASCO 2016 Pancreas indoximod
Apr 20, 2016 ASCO GI 2016 Indoleamine Phase II Trial
Jan 22, 2016 ASCO GI Indoximod + Gemcitabine/nab-Paclitaxel
Dec 15, 2015 SABCS 2015 Indoximod Phase II Metastatic Breast Cancer Trial
Nov 6, 2015 SITC 2015 GDC-0919 + PD-L1
Oct 20, 2015 ECCO-ESMO 2015 Indoximod + Ipilimumab Melanoma Trial
Sep 29, 2015 ESMO 2015 GDC-0919
Jun 1, 2015 ASCO 2015 Indoximod and Temozolomide
Jul 28, 2014 IUMS Highly efficacious influenza vaccination using HyperAcute® Technology
Jun 2, 2014 ASCO 2014 Algenpantucel-L
Jun 2, 2014 ASCO 2014 Sipuleucel-T +- Indoximod
Jun 1, 2014 ASCO 2014 Ad.p53 + Indoximod
Jun 1, 2014 ASCO 2014 Docetaxel + Indoximod
Jun 1, 2014 ASCO 2014 NLG919
Jun 1, 2014 ASCO 2014 Indoximod + Temozolomide
Jun 1, 2014 ASCO 2014 Tergenpumatucel-L vs. Docetaxel
May 31, 2014 ASCO 2014 Indoximod + Ipilimumuab
May 31, 2014 ASCO 2014 Ipilimumab +- Dorgenmeltucel-L
May 30, 2014 Ochsner Journal Combination Immunotherapy for High-Risk Resected ...
Apr 9, 2014 AACR 2014 IDO + PD1 Synergy
Apr 7, 2014 AACR 2014 TDO and IDO
Oct 1, 2013 AACR 2013 NLG919 and Indoximod
Oct 1, 2013 ESMO 2013 HyperAcute®
Aug 2, 2013 ASCO 2013 Algenpantucel-L
Jun 3, 2013 BioWorld Today NewLink's Phase II NSCLC Data Another Immunotherapy Boost
Jun 2, 2013 ASCO 2013 Ad.p53 DC Indoximod
Jun 2, 2013 ASCO 2013 Indoximod Docetaxel
Jun 1, 2013 ASCO 2013 Tergenpumatucel L
= add file to Briefcase